Remove Doctors Remove FDA Remove Prescription Remove Safety
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The FDA needs to study what people do when they see a DTC ad. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. Still, the gatekeeper continues to be their doctor.

Marketing 285
article thumbnail

Another reason change is needed at FDA? Fair balance

World of DTC Marketing

Safety pages on Pharma product websites continue to have high utility. To portray patients, mindless people who blindly believe DTC TV ads and rush to their doctor to ask for a product are inaccurate. Prescription drugs are not the same as items found in a grocery store. This is normal, and the FDA should take note.

FDA 165
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is DTC effective?

World of DTC Marketing

Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. The FDA can be myopic when researching how consumers view and react to DTC.

article thumbnail

Relief for Amylyx as FDA clears controversial ALS drug Relyvrio

pharmaphorum

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug. An oral version of edaravone was cleared this year.

FDA 81
article thumbnail

Healthcare Watch October 2023

PM360

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. doctors are calling two particular drugs “paradigm-shifting”—tirzepatide, sold as Mounjaro , and semaglutide, sold as the brands Ozempic , Wegovy , and Rybelsus.

article thumbnail

Healthcare Watch September 2022

PM360

Doctor Docs: Doctors Left Concerned After Roe v. Abortion bans have made it a felony to provide or attempt to provide an abortion, meaning doctors and clinics are the ones likely to be charged and tried, rather than individual patients. Patient Pages: Patients Refuse Prescription Use After Recalls. Wade Overturn.

article thumbnail

Digital therapeutics and healthcare innovation

pharmaphorum

The development of software applications that are available with a prescription took a major step forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label.